Stocks in Views: Williams Companies, Inc. (NYSE:WMB), Amgen Inc. (NASDAQ:AMGN), Pharmacyclics Inc. (NASDAQ:PCYC)

Pipeline operator Williams Companies Inc. (WMB: Quote) is one of the bidders for QEP Resources Inc.'s (QEP: Quote) natural gas pipeline unit, Entrada Midstream Inc., Bloomberg reported Saturday, citing people familiar with the matter. A sale of the unit could reportedly be worth about $2.5 billion. QEP Resources said in June that its wholly owned subsidiary, QEP Field Services Company or QEPFS, filed a registration statement with the U.S. Securities and Exchange Commission in connection with the spinoff of its midstream field services business into a separate, publicly traded company. On the other consideration, Williams Companies, Inc. (NYSE:WMB) begun last trade with a price of $51.67 and throughout the trading session climbed at $53.28. The day-trade ended with an advance of 2.06% to closed at $52.10. The stock is going forward its fifty-two week low with 58.33% and lagging behind from its 52 week high price with -11.97%. WMB last month stock price volatility remained 3.41%.Amgen Inc. (NASDAQ:AMGN) reported that it filed a court case in the U.S. District Court of Delaware against Sanofi (SNYNF), Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc., and Regeneron Pharmaceuticals Inc. (REGN) for patent infringement of U.S. Patents. These patents, which are owned by Amgen, describe as well as claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 or "PCSK9". Amgen Inc. (NASDAQ:AMGN) stock hit highest price at $139.85, beginning with a price of $131.25 to the closed at 133.69 by an increase of 2.48% with a day range of $129.50-$139.85. The total market capitalization remained 101.6 Billion, total volume of 7.32 Million shares held in the session was surprisingly higher than its average volume of 3418.06 shares.Pharmacyclics Inc. (NASDAQ:PCYC) released that the European Commission or EC has granted marketing permitted for IMBRUVICA throughout the 28 member states of the European Union or EU. Shares of Pharmacyclics Inc. (NASDAQ:PCYC) opened at $113.49 with 75.27 million outstanding shares and hit to its highest price of $116.50 during the day and finally closed at $112.21 by scoring 2.81%. In the whole session, it traded on volume of 1.08 Million shares, which turned higher than its average volume.